TABLE OF CONTENTS
Volume 20, Issue 8 (August 2006)
Reviews
Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies
C López-Pedrera, N Barbarroja, G Dorado, E Siendones and F Velasco
Leukemia 20: 1331-1340; advance online publication, May 25, 2006; doi:10.1038/sj.leu.2404264
Proteasome inhibitor bortezomib for the treatment of multiple myeloma
M Cavo
Leukemia 20: 1341-1352; advance online publication, June 29, 2006; doi:10.1038/sj.leu.2404278
Editorials
Short tandem repeat markers in diagnostics: what's in a repeat?
M G J Tilanus on behalf of the Eurochimerism Consortium
Leukemia 20: 1353-1355; doi:10.1038/sj.leu.2404273
Tissue factor in hematological malignancies
D Ribatti
Leukemia 20: 1356-1357; doi:10.1038/sj.leu.2404269
Chimerism and transplant-related diagnostics
N Muller-Bérat and T Lion
Leukemia 20: 1358-1360; doi:10.1038/sj.leu.2404268
Original Articles
Therapy
Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia
J Jin, D-Z Jiang, W-Y Mai, H-T Meng, W-B Qian, H-Y Tong, J Huang, L-P Mao, Y Tong, L Wang, Z-M Chen and W-L Xu
Leukemia 20: 1361-1367; advance online publication, June 22, 2006; doi:10.1038/sj.leu.2404287
Combinations of the FLT3 inhibitor CEP-701 and chemotherapy synergistically kill infant and childhood MLL-rearranged ALL cells in a sequence-dependent manner
P Brown, M Levis, E McIntyre, M Griesemer and D Small
Leukemia 20: 1368-1376; advance online publication, June 8, 2006; doi:10.1038/sj.leu.2404277
Acute Leukemias
Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia
M Meier, M L den Boer, J P P Meijerink, M J C Broekhuis, M M C J Passier, E R van Wering, G E Janka-Schaub and R Pieters
Leukemia 20: 1377-1384; advance online publication, June 22, 2006; doi:10.1038/sj.leu.2404288
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks
F J T Staal, G Cario, G Cazzaniga, T Haferlach, M Heuser, W-K Hofmann, K Mills, M Schrappe, M Stanulla, L U Wingen, J J M van Dongen and B Schlegelberger
Leukemia 20: 1385-1392; advance online publication, June 8, 2006; doi:10.1038/sj.leu.2404274
Molecular response in acute promyelocytic leukemia: a direct comparison of regular and real-time RT-PCR
Y-F Liu, Y-M Zhu, S-H Shen, Z-X Shen, J-M Li, S-J Chen, Z Chen and H U Jiong
Leukemia 20: 1393-1399; advance online publication, May 25, 2006; doi:10.1038/sj.leu.2404262
Chronic Myeloid Leukemia and Myeloproliferative Disorders
Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients
O Frank, B Brors, A Fabarius, L Li, M Haak, S Merk, U Schwindel, C Zheng, M C Müller, N Gretz, R Hehlmann, A Hochhaus and W Seifarth
Leukemia 20: 1400-1407; advance online publication, May 25, 2006; doi:10.1038/sj.leu.2404270
Minimal Residual Disease
Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO + acute myelogenous leukemia
H W Moon, S Shin, H Y Kim, Y R Kim, H I Cho, S S Yoon, S Park, B K Kim, H Chun, H C Kim, C J Park, Y H Min and D S Lee
Leukemia 20: 1408-1413; advance online publication, June 22, 2006; doi:10.1038/sj.leu.2404286
Oncogenes, Fusion Genes and Tumor Suppressor Genes
FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation
H A Vu, P T Xinh, M Masuda, T Motoji, A Toyoda, Y Sakaki, K Tokunaga and Y Sato
Leukemia 20: 1414-1421; advance online publication, June 8, 2006; doi:10.1038/sj.leu.2404266
Lymphoma
Loss of heterozygosity on chromosome 6q14–q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma
B Burkhardt, J Bruch, M Zimmermann, K Strauch, R Parwaresch, W-D Ludwig, L Harder, B Schlegelberger, F Mueller, J Harbott and A Reiter
Leukemia 20: 1422-1429; advance online publication, June 1, 2006; doi:10.1038/sj.leu.2404275
Normal Hemopoiesis
Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor
G Cella, M Marchetti, A Vignoli, M L Randi, G Saggiorato, L Pasetto, A Pagnan, T Barbui and A Falanga
Leukemia 20: 1430-1434; advance online publication, June 15, 2006; doi:10.1038/sj.leu.2404271
Letters to the Editor
Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia
H Graf Einsiedel, L Kawan, C Eckert, O Witt, I Fichtner, G Henze and K Seeger
Leukemia 20: 1435-1436; advance online publication, June 29, 2006; doi:10.1038/sj.leu.2404282
Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions
S Verheyden and C Demanet
Leukemia 20: 1437-1438; advance online publication, June 8, 2006; doi:10.1038/sj.leu.2404279
The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells
K Pulford, A H Banham, L Lyne, M Jones, G C Ippolito, H Liu, P W Tucker, G Roncador, E Lucas, S Ashe, L Stockwin, R Walewska, L Karran, R D Gascoyne, D Y Mason and M J S Dyer
Leukemia 20: 1439-1441; advance online publication, May 18, 2006; doi:10.1038/sj.leu.2404260
Alemtuzumab in combination with high-dose methylprednisolone is a logical, feasible and highly active therapeutic regimen in chronic lymphocytic leukaemia patients with p53 defects
A R Pettitt, E Matutes and D Oscier
Leukemia 20: 1441-1445; advance online publication, June 1, 2006; doi:10.1038/sj.leu.2404265
Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome
J Roman-Gomez, A Jimenez-Velasco, X Agirre, J A Castillejo, G Navarro, L Garate, E San Jose-Eneriz, L Cordeu, M Barrios, F Prosper, A Heiniger and A Torres
Leukemia 20: 1445-1447; advance online publication, May 11, 2006; doi:10.1038/sj.leu.2404257
The RSD code: proposal for a nomenclature of allelic configurations in STR-PCR-based chimerism testing after allogeneic stem cell transplantation
F Watzinger, T Lion and C Steward on behalf of the Eurochimerism consortium
Leukemia 20: 1448-1452; advance online publication, June 1, 2006; doi:10.1038/sj.leu.2404267
Granulocyte colony stimulating factor administration associated with cerebral hemorrhage in acute promyelocytic leukemia
A-M Tsimberidou, E Estey, H Kantarjian, M J Keating, S Pierce and G Garcia-Manero
Leukemia 20: 1452-1453; advance online publication, May 25, 2006; doi:10.1038/sj.leu.2404272
JAK2 mutation in a boy with polycythemia vera, but not in other pediatric hematologic Disorders
M-J Park, A Shimada, H Asada, K Koike, M Tsuchida and Y Hayashi
Leukemia 20: 1453-1454; advance online publication, May 18, 2006; doi:10.1038/sj.leu.2404259
Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia
M Mosor, I Zió
kowska, M Pernak-Schwarz, D Januszkiewicz-Lewandowska and J Nowak
Leukemia 20: 1454-1456; advance online publication, June 29, 2006; doi:10.1038/sj.leu.2404285
Functional capacity of Mcl-1-specific cytotoxic T-cells
R B Sørensen, O J Nielsen, P thor Straten and M H Andersen
Leukemia 20: 1457-1458; advance online publication, May 25, 2006; doi:10.1038/sj.leu.2404261
Development of megakaryoblastic leukaemia in Runx1-Evi1 knock-in chimaeric mouse
K Maki, T Yamagata, I Yamazaki, H Oda and K Mitani
Leukemia 20: 1458-1460; advance online publication, June 8, 2006; doi:10.1038/sj.leu.2404281
The role of the bax gene polymorphism G(-248)A in chronic lymphocytic leukemia
C Fegan, J Starczynski, G Pratt and C Pepper
Leukemia 20: 1460-1461; advance online publication, June 8, 2006; doi:10.1038/sj.leu.2404280
Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell source
D Gallardo, A Pérez-García, R de la Cámara, A Iriondo, A Jiménez-Velasco, A Torres, S Brunet, Á Urbano-Ispizúa, C Vallejo, M Encuentra, D Caballero, I Espigado, D Serrano, C Barrenetxea, J M Ribera and J de la Rubia On behalf of the Allogeneic Peripheral Blood Transplantation Sub-committee of the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH: Grupo Español de Trasplante Hemopoyético)
Leukemia 20: 1461-1464; advance online publication, May 25, 2006; doi:10.1038/sj.leu.2404263
